V019-0371 Screening compound: 2-{6-[2-(2-chlorophenoxy)acetyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl}-N-[2-(piperidin-1-yl)ethyl]propanamide

V019-0371 Screening compound: 2-{6-[2-(2-chlorophenoxy)acetyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl}-N-[2-(piperidin-1-yl)ethyl]propanamide
V019-0371 Screening compound: 2-{6-[2-(2-chlorophenoxy)acetyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl}-N-[2-(piperidin-1-yl)ethyl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-0371
2-{6-[2-(2-chlorophenoxy)acetyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl}-N-[2-(piperidin-1-yl)ethyl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-0371

Molecular Formula

C26H30ClN3O5 (C26 H30 ClN3 O5)

Compound Name

2-{6-[2-(2-chlorophenoxy)acetyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl}-N-[2-(piperidin-1-yl)ethyl]propanamide

IUPAC name

2-{6-[2-(2-chlorophenoxy)acetyl]-3-oxo-34-dihydro-2H-14-benzoxazin-4-yl}-N-[2-(piperidin-1-yl)ethyl]propanamide

SMILES

CC(C(NCCN1CCCCC1)=O)N1c(cc(cc2)C(COc(cccc3)c3Cl)=O)c2OCC1=O

InChI

InChI=1S/C26H30ClN3O5/c1-18(26(33)28-11-14-29-12-5-2-6-13-29)30-21-15-19(9-10-24(21)35-17-25(30)32)22(31)16-34-23-8-4-3-7-20(23)27/h3-4,7-10,15,18H,2,5-6,11-14,16-17H2,1H3,(H,28,33)/t18-/m0/s1

InChI Key

RBKNEIVKSQJZCY-SFHVURJKSA-N

MDL Number (MFCD)

MFCD19890438

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

499.99

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.426

Distribution Coefficient, logD

0.833

Water Solubility, LogSw

-3.40

Polar Surface Area

72.479

Acid Dissociation Constant (pKa)

13.53

Base Dissociation Constant (pKb)

8.98

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

42.30

V019-0371 in Drug Discovery

Included in Screening Libraries

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
Targets:
  • GPCR
  • Ion Channels

References: we are preparing a list of scientific research reports with V019-0371 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-0371?
Check Price and Availability of V019-0371, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-0371 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-0371
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-0371
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-0371 available by request